100 related articles for article (PubMed ID: 22991231)
1. 18β-glycyrrhetinic acid inhibits hepatocellular carcinoma development by reversing hepatic stellate cell-mediated immunosuppression in mice.
Kuang P; Zhao W; Su W; Zhang Z; Zhang L; Liu J; Ren G; Yin Z; Wang X
Int J Cancer; 2013 Apr; 132(8):1831-41. PubMed ID: 22991231
[TBL] [Abstract][Full Text] [Related]
2. Activated hepatic stellate cells promote hepatocellular carcinoma development in immunocompetent mice.
Zhao W; Zhang L; Yin Z; Su W; Ren G; Zhou C; You J; Fan J; Wang X
Int J Cancer; 2011 Dec; 129(11):2651-61. PubMed ID: 21213212
[TBL] [Abstract][Full Text] [Related]
3. Bear bile inhibits the immunosuppression activity of hepatic stellate cells in vivo.
Zhou CS; Yin ZY; Zhao WX; Zhang L; You JY; Su WX; Fan J; Wang XM
Hepatogastroenterology; 2012; 59(117):1529-36. PubMed ID: 22683969
[TBL] [Abstract][Full Text] [Related]
4. T-cell apoptosis induced by intratumoral activated hepatic stellate cells is associated with lung metastasis in hepatocellular carcinoma.
Xia YH; Wang ZM; Chen RX; Ye SL; Sun RX; Xue Q; Huang Y
Oncol Rep; 2013 Sep; 30(3):1175-84. PubMed ID: 23807027
[TBL] [Abstract][Full Text] [Related]
5. The role of hepatic stellate cells in the regulation of T-cell function and the promotion of hepatocellular carcinoma.
Zhao W; Su W; Kuang P; Zhang L; Liu J; Yin Z; Wang X
Int J Oncol; 2012 Aug; 41(2):457-64. PubMed ID: 22641338
[TBL] [Abstract][Full Text] [Related]
6. Sorafenib relieves cell-intrinsic and cell-extrinsic inhibitions of effector T cells in tumor microenvironment to augment antitumor immunity.
Chen ML; Yan BS; Lu WC; Chen MH; Yu SL; Yang PC; Cheng AL
Int J Cancer; 2014 Jan; 134(2):319-31. PubMed ID: 23818246
[TBL] [Abstract][Full Text] [Related]
7. Hepatic stellate cells promote tumor progression by enhancement of immunosuppressive cells in an orthotopic liver tumor mouse model.
Zhao W; Zhang L; Xu Y; Zhang Z; Ren G; Tang K; Kuang P; Zhao B; Yin Z; Wang X
Lab Invest; 2014 Feb; 94(2):182-91. PubMed ID: 24296878
[TBL] [Abstract][Full Text] [Related]
8. 18α-glycyrrhetinic acid extracted from Glycyrrhiza radix inhibits proliferation and promotes apoptosis of the hepatic stellate cell line.
Zong L; Qu Y; Xu MY; Dong YW; Lu LG
J Dig Dis; 2013 Jun; 14(6):328-36. PubMed ID: 23362936
[TBL] [Abstract][Full Text] [Related]
9. Activated hepatic stellate cells promote liver cancer by induction of myeloid-derived suppressor cells through cyclooxygenase-2.
Xu Y; Zhao W; Xu J; Li J; Hong Z; Yin Z; Wang X
Oncotarget; 2016 Feb; 7(8):8866-78. PubMed ID: 26758420
[TBL] [Abstract][Full Text] [Related]
10. Hepatic stellate cells activated by acidic tumor microenvironment promote the metastasis of hepatocellular carcinoma via osteopontin.
Song J; Ge Z; Yang X; Luo Q; Wang C; You H; Ge T; Deng Y; Lin H; Cui Y; Chu W; Yao M; Zhang Z; Gu J; Fan J; Qin W
Cancer Lett; 2015 Jan; 356(2 Pt B):713-20. PubMed ID: 25449435
[TBL] [Abstract][Full Text] [Related]
11. Fatty liver creates a pro-metastatic microenvironment for hepatocellular carcinoma through activation of hepatic stellate cells.
Mikuriya Y; Tashiro H; Kuroda S; Nambu J; Kobayashi T; Amano H; Tanaka Y; Ohdan H
Int J Cancer; 2015 Feb; 136(4):E3-13. PubMed ID: 25053237
[TBL] [Abstract][Full Text] [Related]
12. Binding effect of fluorescence labeled glycyrrhetinic acid with GA receptors in hepatocellular carcinoma cells.
Sun YQ; Dai CM; Zheng Y; Shi SD; Hu HY; Chen DW
Life Sci; 2017 Nov; 188():186-191. PubMed ID: 28768154
[TBL] [Abstract][Full Text] [Related]
13. Combined anti-hepatocellular carcinoma therapy inhibit drug-resistance and metastasis via targeting "substance P-hepatic stellate cells-hepatocellular carcinoma" axis.
Li Z; Wang F; Li Y; Wang X; Lu Q; Wang D; Qi C; Li C; Li Z; Lian B; Tian G; Gao Z; Zhang B; Wu J
Biomaterials; 2021 Sep; 276():121003. PubMed ID: 34273686
[TBL] [Abstract][Full Text] [Related]
14. 18β-Glycyrrhetinic acid potently inhibits Kv1.3 potassium channels and T cell activation in human Jurkat T cells.
Fu XX; Du LL; Zhao N; Dong Q; Liao YH; Du YM
J Ethnopharmacol; 2013 Jul; 148(2):647-54. PubMed ID: 23707333
[TBL] [Abstract][Full Text] [Related]
15. Hepatic stellate cell-targeted delivery of M6P-HSA-glycyrrhetinic acid attenuates hepatic fibrogenesis in a bile duct ligation rat model.
Luk JM; Zhang QS; Lee NP; Wo JY; Leung PP; Liu LX; Hu MY; Cheung KF; Hui CK; Lau GK; Fan ST
Liver Int; 2007 May; 27(4):548-57. PubMed ID: 17403195
[TBL] [Abstract][Full Text] [Related]
16. Hepatic stellate cells attenuate the immune response in renal transplant recipients with chronic hepatitis.
Su YH; Shu KH; Hu C; Cheng CH; Wu MJ; Yu TM; Chuang YW; Huang ST; Chen CH
Transplant Proc; 2012 Apr; 44(3):725-9. PubMed ID: 22483478
[TBL] [Abstract][Full Text] [Related]
17. [18β-glycyrrhetinic acid piperazine derivative A30 inhibits the proliferation of SMMC-7721 hepatoma cells].
Zhong L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Sep; 33(9):1212-1216. PubMed ID: 29089079
[TBL] [Abstract][Full Text] [Related]
18. Cotransplantation of hepatic stellate cells attenuates the severity of graft-versus-host disease.
Chen CH; Shu KH; Su YH; Tang KY; Cheng CH; Wu MJ; Yu TM; Chuang YW; Hu C
Transplant Proc; 2010 Apr; 42(3):971-5. PubMed ID: 20430218
[TBL] [Abstract][Full Text] [Related]
19. Suppression of hepatocellular carcinoma by transplantation of ex-vivo immune-modulated NKT lymphocytes.
Margalit M; Shibolet O; Klein A; Elinav E; Alper R; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
Int J Cancer; 2005 Jun; 115(3):443-9. PubMed ID: 15688366
[TBL] [Abstract][Full Text] [Related]
20. NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen-pulsed dendritic cells.
Shibolet O; Alper R; Zlotogarov L; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
Int J Cancer; 2003 Aug; 106(2):236-43. PubMed ID: 12800200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
